Asia Pacific Healthcare Electronic Data Interchange (EDI) Market Size and Forecasts (2020 – 2030)

Asia Pacific Healthcare Electronic Data Interchange (EDI) Market Size and Forecasts (2020 – 2030), Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Component (Solution and Services), Delivery Mode [Web-Based & Cloud-Based, EDI Value Added Networks (VANs), Direct/Point-to-Point EDI, Mobile EDI, and Others], Application (Claims Management and Healthcare Supply Chain), End User (Healthcare Providers, Healthcare Payers, Medical & Pharmaceutical Industries, and Pharmacies), and Regional Analysis

Send Enquiry
Item ID: TIPRE00030244 Category: Tags: , ,

$2,100$3,500

Description

The Asia Pacific healthcare EDI market is expected to grow from US$ 0.409 billion in 2022 to US$ 1.208 billion by 2030; it is expected to grow at a CAGR of 14.5% from 2022 to 2028. Growing need for seamless processing of healthcare claims and administrative transactions and increasing adoption of healthcare EDI platform in supply chain tracking are a few factors driving the Asia Pacific healthcare EDI market growth.

Electronic data interchange (EDI) in healthcare is a secure way of transmitting data between healthcare institutions, insurers, and patients using established message formats and standards.

Increasing Adoption of Healthcare EDI Platform in Supply Chain Tracking

Hospitals face unprecedented pressure to improve the traditional supply chain process, ultimately reducing cost, quality, and customer experience. Three of the most common issues in the healthcare industry’s supply chain are inadequate inventory management, manual data entry errors, and regulatory compliance and reporting. For example, when medical product suppliers do not utilize healthcare EDI, the healthcare organizations need help in delivering quality patient care, and suppliers lose competitive advantage over other suppliers, spoiling business relationships. Therefore, incorporating healthcare EDI in the supply chain offers the best solution to mitigate supply chain errors. For example, healthcare EDI enables real-time communication of maintaining inventory levels in the medical device industry.

EDI also provides more accurate demand forecasts and allows healthcare suppliers to maintain inventories with the products their customers need and ultimately optimize inventory levels. Further, EDI reduces manual data entry errors across the supply chain by automating the exchange of information between trading partners and ensuring the accurate and consistent transmission of data across the supply chain, keeping the order fulfillment process streamlined and accurate. The EDI also manages regulatory compliance and reporting across the supply chain. For example, by properly utilizing the healthcare EDI transactions, healthcare product suppliers can take advantage of the automatic generation and exchange of necessary documents related to regulatory compliance and build an electronic audit record demonstrating compliance. Furthermore, medical product suppliers can take advantage of cloud-based EDI managed services, EDI value-added networks (VANs), and EDI training and consulting services. “Cloud-Based EDI Managed Services” and “EDI Value-Added Network (VAN)” solutions offered by the GraceBlood LLC. company are among such examples. EDI Managed Services automate the process in order to help the business grow in less time. Cloud-based EDI-managed services utilize fewer resources and help meet the ever-changing demand of the supply chain, resulting in growing business more than ever before. Additionally, EDI VAN has proven the scalability and service levels through features such as Open Web Services, APIs, and Fully Cloud-Enabled Architecture with minimum supply chain-associated cost. Therefore, the utilization of healthcare EDI in supply chain processes ultimately drives market growth through limited resource utilization and cost.

Market Trends

Technological Advancements in Healthcare EDI

Healthcare organizations deal with vast amount of data every day, starting from patient records and claims to lab results and prescriptions. ~50% of the hospitals in the US have unstructured data, causing a major hindrance in improving the overall healthcare interoperability and connected care initiatives, as per the published report in 2023 by Astera Software. Therefore, technological advancements stand as a reliable solution that can help hospitals overcome challenges associated with hospital-generated data. The Pilotfish’s “ei Console for X12” launched in 2020 is one such example of technological advancement in healthcare EDI. Pilotfish is the only solution that validates healthcare X12 EDI data, translates it, and maps it from any other application by delivering features and modules by reducing minimal complexity. Also, the “eiConsole” for X12 EDI includes an EDI Format Builder that loads a rich data dictionary for EDI transactions, such as field-level documentation and friendly source names. Also, in the eiConsole, the EDI format reader provides automatic prices and reads in X12 transactions.

In September 2022, Prodigo Solutions announced the release of its next-generation EDI platform “Xchange” for healthcare clients that leverage supply chain modernization initiatives and automate transaction processes. This next-generation Xchange has a significantly faster processing time with a small memory footprint to support the ever-increasing volume of EDI documents being transmitted between trading partners. Therefore, with technological advancements in healthcare EDI features, the overall operational efficiency of the healthcare industry is likely to improve, which will promote the market growth during the forecast period.

The “Asia Pacific Healthcare EDI Market” is segmented on the basis of component, delivery mode, application, end user, and region. Based on component, the solution segment accounted for a larger share in 2022. Based on delivery mode, the web-based & cloud based segment dominated the market by accounting maximum share. By application, claims management segment dominated the market by accounting maximum share. By end user segment, the healthcare providers segment is likely to account for a considerable share of the healthcare EDI market during the forecast period.

Based on component, the healthcare EDI market is bifurcated into solution and services. The solution segment held the largest share of the market in 2022 and the same segment is anticipated to register the highest CAGR of 14.9% in the market during the forecast period. Electronic data interchange (EDI) solution comprises data conversion in readable formats, interoperability, IT tools, and data security. For example, the current version of the EDI solution includes standardized messaging to enable seamless information exchange within healthcare organizations. Also, top companies such as IBM provide “IBM WebSphere Data Interchange” solutions that support service-oriented architecture (SOA) and business process management (BPM) implementation. Also, the “IBM WebSphere Data Interchange” solution facilitates the creation, deployment, execution, and management of data transformation and related standards-based processing between standard-based EDI formats and internal application data formats. The IBM WebSphere Data Interchange is utilized in multiple industries, including healthcare. The aforementioned factors are responsible for influential growth of the segment growth.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

According to our new research study on “Asia Pacific Healthcare EDI Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Technology, Application, End User, and Region,” the Asia Pacific healthcare EDI market is expected to grow from US$ 0.409 billion in 2022 to US$ 1.208 billion by 2030; it is estimated to register a CAGR of 14.5% during the forecast period. The growing need for seamless processing of healthcare claims and administrative transactions and increasing adoption of healthcare EDI platform in supply chain tracking are the major factors contributing to the market growth.

Increasing Adoption of Healthcare EDI Platform in Supply Chain Tracking

Hospitals face unprecedented pressure to improve the traditional supply chain process, ultimately reducing cost, quality, and customer experience. Three of the most common issues in the healthcare industry’s supply chain are inadequate inventory management, manual data entry errors, and regulatory compliance and reporting. For example, when medical product suppliers do not utilize healthcare EDI, the healthcare organizations need help in delivering quality patient care, and suppliers lose competitive advantage over other suppliers, spoiling business relationships. Therefore, incorporating healthcare EDI in the supply chain offers the best solution to mitigate supply chain errors. For example, healthcare EDI enables real-time communication of maintaining inventory levels in the medical device industry.

EDI also provides more accurate demand forecasts and allows healthcare suppliers to maintain inventories with the products their customers need and ultimately optimize inventory levels. Further, EDI reduces manual data entry errors across the supply chain by automating the exchange of information between trading partners and ensuring the accurate and consistent transmission of data across the supply chain, keeping the order fulfillment process streamlined and accurate. The EDI also manages regulatory compliance and reporting across the supply chain. For example, by properly utilizing the healthcare EDI transactions, healthcare product suppliers can take advantage of the automatic generation and exchange of necessary documents related to regulatory compliance and build an electronic audit record demonstrating compliance. Furthermore, medical product suppliers can take advantage of cloud-based EDI managed services, EDI value-added networks (VANs), and EDI training and consulting services. “Cloud-Based EDI Managed Services” and “EDI Value-Added Network (VAN)” solutions offered by the GraceBlood LLC. company are among such examples. EDI Managed Services automate the process in order to help the business grow in less time. Cloud-based EDI-managed services utilize fewer resources and help meet the ever-changing demand of the supply chain, resulting in growing business more than ever before. Additionally, EDI VAN has proven the scalability and service levels through features such as Open Web Services, APIs, and Fully Cloud-Enabled Architecture with minimum supply chain-associated cost. Therefore, the utilization of healthcare EDI in supply chain processes ultimately drives market growth through limited resource utilization and cost.

?

Market Opportunities

Outsourcing Healthcare EDI Services

EDI implementation through third-party/outsourced solutions saves time, internal resources, and implementation costs. For example, EDI, through outsourced solutions, provides a wide range of pricing models to the organization, with the majority being subscription models. Therefore, the majority of the providers are charged based on the volume of data transmitted through EDI networks.

Table 1. Subscription Models to the Organization

Pay As You Go Monthly Annual Subscription

Source:the research team Analysis

Although an in-house solution provides the advantage of complete internal management, security, and control, it incurs high cost of EDI implementation. Therefore, a majority of organizations choose to utilize a third-party EDI provider that addresses all the electronic data interchange within the departments with less cost of implementation. A minimal EDI cost through third-party providers helps small and medium-sized businesses manage EDI implementation costs and launch in-house EDI infrastructure with a minimum budget. Therefore, the calculation of EDI implementation cost is critical to determine the actual financial and business benefits to the organization. If any organization fails to calculate the finance related to healthcare EDI cost implementation, it significantly affects the revenue side of the organization. Therefore, utilizing outsourcing EDI services provides a lucrative opportunity for the market growth.

Siemens Healthineers AG, GE Healthcare Technologies Inc., Wipro Ltd., athenahealth Inc., PNORS Technology Group Pty Ltd, International Business Machines Corp, Cognizant Technology Solutions Corp, Veradigm Inc, Oracle Corp, McKesson Corp, and Optum Inc are among the leading companies operating in the Asia Pacific healthcare EDI market.

The “Asia Pacific Healthcare EDI Market” is segmented on the basis of component, delivery mode, application, end user, and region.

.

In Jun-2023, Cognizant announced an expansion of their long-standing healthcare collaboration with Microsoft, to give healthcare payers and providers easy access to cutting-edge technology solutions, streamlined claims management, and improved interoperability to optimize business operations and deliver better patient and member experiences.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Eye Drops Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
4.4 Pipeline Analysis
5. Asia Pacific Eye Drops Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Ophthalmic Diseases
5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
5.4.1 Changing Lifestyle
5.5 Impact Analysis
6. Eye Drops Market – Asia Pacific Market Analysis
6.1 Asia Pacific Eye Drops Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Asia Pacific Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
7.4.1 Overview
7.4.2 Artificial Tears: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
7.5.1 Overview
7.5.2 Hormones: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Asia Pacific Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
8.3.1 Overview
8.3.2 Eye Diseases: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Dry Eye
8.3.2.1.1 Overview
8.3.2.2 Dry Eye: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Glaucoma
8.3.2.3.1 Overview
8.3.2.3.2 Glaucoma: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Cataract
8.3.2.4.1 Overview
8.3.2.4.2 Cataract: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
8.4.1 Overview
8.4.2 Eye Care: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 – by Purchase Mode
9.1 Overview
9.2 Asia Pacific Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
9.3.1 Overview
9.3.2 Prescription: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
9.4.1 Overview
9.4.2 OTC: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Asia Pacific Eye Drops Market
10.1.1 Overview
10.1.2 Asia Pacific Eye Drops Market, by Country, 2022 & 2030 (%)
10.1.2.1 China: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 China: Asia Pacific Eye Drops Market, by Drug Class, 2020–2030 (US$ Million)
10.1.2.1.4 China: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.1.4.1 China: Asia Pacific Eye Drops Market, by Eye Disease, 2020–2030 (US$ Million)
10.1.2.1.5 China: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.2 Japan: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Japan: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.2.4 Japan: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.2.4.1 Japan: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.2.5 Japan: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.3 India: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 India: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.3.4 India: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.3.4.1 India: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.3.5 India: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.4 Australia: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.3 Australia: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.4.4 Australia: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.4.4.1 Australia: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.4.5 Australia: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.5 South Korea: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.3 South Korea: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.5.4 South Korea: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.5.4.1 South Korea: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.5.5 South Korea: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.6 Rest of Asia Pacific: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.6.4.1 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
11. Asia Pacific Eye Drops Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Alcon AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pfizer Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Prestige Consumer Healthcare Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Rohto Pharmaceutical Co Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 AbbVie Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bausch & Lomb Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biomedica Pvt Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Surgical Navigation Systems Market Segmentation
Table 2. Commonly Used ASC X12 Transactions in Dental Industry
Table 3. Subscription Models to the Organization
Table 4. Asia Pacific: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Component
Table 5. Asia Pacific: Healthcare EDI Market Revenue and Forecast To 2030 (US$ Mn) – Delivery Mode
Table 6. Asia Pacific: Healthcare EDI Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 7. Asia Pacific: Healthcare EDI Market Revenue and Forecast To 2030 (US$ Mn) – Claims Management
Table 8. Asia Pacific: Healthcare EDI Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 9. China: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Component
Table 10. China: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Delivery Mode
Table 11. China: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 12. China: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Claims Management
Table 13. China: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. Japan: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Component
Table 15. Japan: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Delivery Mode
Table 16. Japan: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 17. Japan: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Claims Management
Table 18. India: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Component
Table 19. India: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Delivery Mode
Table 20. India: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 21. India: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Claims Management
Table 22. India: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 23. South Korea: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Component
Table 24. South Korea: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Delivery Mode
Table 25. South Korea: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 26. South Korea: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Claims Management
Table 27. South Korea: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 28. GS1 Model for Supply Chain Management in Healthcare in Australia
Table 29. Australia: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Component
Table 30. Australia: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Delivery Mode
Table 31. Australia: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 32. Australia: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Claims Management
Table 33. Australia: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 34. Rest of Asia Pacific: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Component
Table 35. Rest of Asia Pacific: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Delivery Mode
Table 36. Rest of Asia Pacific: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 37. Rest of Asia Pacific: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – Claims Management
Table 38. Rest of Asia Pacific: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 39. Organic Developments Done by Companies
Table 40. Inorganic Developments Done by Companies
Table 41. Glossary of Terms

LIST OF FIGURES

Figure 1. Asia Pacific Electronic Data Interchange (EDI) Market, by Region
Figure 2. Key Insights
Figure 3. Asia Pacific: PEST Analysis
Figure 4. Asia Pacific Healthcare Electronic Data Interchange (EDI) Market- Key Industry Dynamics
Figure 5. Asia Pacific Healthcare Electronic Data Interchange (EDI) Market: Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue Forecast and Analysis – 2021–2030
Figure 7. Asia Pacific Healthcare Electronic Data Interchange (EDI) Market Revenue Share, by Component, 2022 & 2030 (%)
Figure 8. Solution: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Services: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Asia Pacific Healthcare Electronic Data Interchange (EDI) Market Revenue Share, by Delivery Mode (2022 and 2030)
Figure 11. Web-Based & Cloud Based: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. EDI Value Added Network (VAN): Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Direct/Point-to-Point EDI: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Mobile EDI: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Asia Pacific Healthcare Electronic Data Interchange (EDI) Market Revenue Share, by Application (2022 and 2030)
Figure 17. Claims Management: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Claims Submission: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Claims Status: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Eligibility Criteria: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Payment Remittance: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Referral Certification & Authorization: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Healthcare Supply Chain: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Healthcare Electronic Data Interchange (EDI) Market Revenue Share, by End User (2022 and 2030)
Figure 26. Healthcare Providers: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Healthcare Payers: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Medical & Pharmaceutical Industries: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Pharmacies: Asia Pacific Healthcare Electronic Data Interchange (EDI) Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Healthcare EDI Market, 2022 ($Mn)
Figure 31. Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Asia Pacific: Healthcare EDI Market, By Key Countries, 2022 And 2030 (%)
Figure 33. China: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Japan: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. India: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. South Korea: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Australia: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Asia Pacific: Healthcare EDI Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Growth Strategies in the Asia Pacific Electronic Data Interchange (EDI) Market

The List of Companies – Asia Pacific Healthcare EDI Market
– Siemens Healthineers AG                
– GE HealthCare Technologies Inc    
– Wipro Ltd               
– athenahealth Inc                 
– PNORS Technology Group Pty Ltd                 
– International Business Machines Corp        
– Cognizant Technology Solutions Corp         
– Veradigm Inc         
– Oracle Corp           
– McKesson Corp    
– Optum Inc

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Healthcare Electronic Data Interchange (EDI) Market Size and Forecasts (2020 – 2030)”